Myotec Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Warnings Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Mycophenolate mofetil

Indications/Uses

Prevention of graft rejection & has also been tried in diseases w/ an autoimmune or immune-mediated inflammatory component w/ other immunosuppressants.

Click to view Myotec detailed prescribing information

Dosage/Direction for Use

Adult & elderly Renal transplantation 1 g bid. Cardiac & hepatic transplantation 1.5 g bid.

Click to view Myotec detailed prescribing information

Overdosage

View Myotec overdosage for action to be taken in the event of an overdose.

Administration

May be taken with or without food: Swallow whole, do not crush/open. In stable renal transplant patients, may be administered w/ meals if necessary.

Contraindications

Hypersensitivity to mycophenolate mofetil or mycophenolic acid.

Click to view Myotec detailed prescribing information

Warnings

For additional cautionary notes to warn of the potential risk of using the medicine... Click to view Myotec detailed prescribing information

Special Precautions

Monitor lymphomas & other malignancies particularly of the skin; infections or sepsis; lymphoproliferative disease or lymphoma; neutropenia; GI bleeding. Avoid concomitant use w/ live attenuated vaccines. Perform CBC wkly during the 1st mth, twice mthly for the 2nd & 3rd mth, then mthly through the 1st yr. Pregnancy & lactation. Childn receiving allogeneic cardiac or hepatic transplantation. Elderly.

Click to view Myotec detailed prescribing information

Use In Pregnancy & Lactation

Click to view Myotec detailed prescribing information

Adverse Reactions

Infections & infestations; benign, malignant & unspecified neoplasms; blood & lymphatic, metabolism & nutrition, psychiatric, nervous system, cardiac, vascular, resp, thoracic & mediastinal, GI, hepatobiliary, skin & SC tissue, musculoskeletal & connective tissue, renal & urinary disorders; general disorders & administration site conditions.

Click to view Myotec detailed prescribing information

Drug Interactions

Increased plasma conc w/ acyclovir. Cholestyramine & other agents that may interfere w/ enterohepatic recirculation. OCs; rifampin. Antacids containing Mg & Al hydroxides (do not administer simultaneously).

Click to view Myotec detailed prescribing information

Storage

View Myotec storage conditions for details to ensure optimal shelf-life.

Description

View Myotec description for details of the chemical structure and excipients (inactive components).

Action

View Myotec mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Immunosuppressants

ATC Classification

L04AA06 - mycophenolic acid ; Belongs to the class of selective immunosuppressive agents. Used to induce immunosuppression.

Regulatory Classification

Presentation/Packing

Form

Myotec film-coated tab 250 mg

Packing/Price

60's

Form

Myotec film-coated tab 500 mg

Packing/Price

60's

Myotec

mycophenolic acid

Manufacturer:

United Biotech

Distributor:

Triple Tact

Marketer:

A-Z Med Inc